As of 2025-12-21, the Intrinsic Value of Revive Therapeutics Ltd (RVV.CN) is -0.03 CAD. This RVV.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.01 CAD, the upside of Revive Therapeutics Ltd is -418.53%.
Based on its market price of 0.01 CAD and our intrinsic valuation, Revive Therapeutics Ltd (RVV.CN) is overvalued by 418.53%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.03 - -0.03 | -0.03 | -418.53% |
| P/E | (0.14) - (0.19) | (0.16) | -1737.3% |
| DDM - Stable | (0.08) - (0.53) | (0.31) | -3196.9% |
| DDM - Multi | (0.00) - (0.01) | (0.00) | -132.4% |
| Market Cap (mil) | 6.28 |
| Beta | 2.55 |
| Outstanding shares (mil) | 627.85 |
| Enterprise Value (mil) | 6.30 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.18% |
| Cost of Debt | 5.00% |
| WACC | 7.16% |